24 Apr Annual Analysts Briefing
Presentation to the Hellenic Fund and Asset Management Association
Paiania, 24 April 2024 – Lavipharm held today its Annual Analysts Briefing, in accordance with the Company’s financial calendar for 2024. The presentation took place at the Athens Exchange to the members of the Hellenic Fund and Asset management Association.
Welcoming the participants, Vassilis Baloumis, Group CFO, commented, “I am very pleased that we are gathered here again, for the second consecutive year. I am also very pleased by what Lavipharm has accomplished in such a relatively short time, under the leadership of Telemaque Lavidas and a dynamic management team. For one more year, we have exceeded our targets, as also reflected in the progress of our stock price, generating value for our shareholders”. Mr. Baloumis then presented….